Evaluation of the Sphingolipid Metabolite S1P as a Novel Biomarker in Food Allergy
NCT01776489 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2015-12-11
Summary
Food allergies represent an increasing health concern in the industrialized countries and especially affect pediatric patients. In this population adverse reactions against food compounds can lead to anaphylactic reactions. Despite substantial research efforts, clinical markers predicting disease severity and symptoms are missing to date.
Recent studies have revealed that sphingolipids, especially sphingosine-1-phosphate (S1P), play an essential role in allergy. It was reported that asthmatic patients have higher S1P levels in bronchiallavage fluids after allergen challenge. First experimental studies revealed a correlation of S1P and the outcome of anaphylaxis. Furthermore, we have shown in our recent mouse study that S1P homeostasis is pivotal for food allergy induction and effector cell response. Therefore, it is the aim of the presented pilot project to evaluate whether S1P serum titers are altered in food allergic children and if the S1P levels correlate with the outcome of anaphylaxis during double blind placebo controlled food challenges (DBPCFCs).
Conditions
Sponsors & Collaborators
-
Medical University of Vienna
lead OTHER
Principal Investigators
-
Eva Untersmayr-Elsenhuber, MD, PhD · Medical University Vienna, Department of Pathophysiology and Allergy Research
Eligibility
- Min Age
- 12 Months
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2017-01-31
- Completion
- 2017-01-31
Countries
- Austria
Study Locations
More Related Trials
-
Food Allergy Registry at a Single Site
NCT03539705 ·Status: RECRUITING
-
Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site
NCT03539692 ·Status: RECRUITING
-
Microbiota and Allergy
NCT04750980 ·Status: COMPLETED
-
Sublingual Immunotherapy for Food Allergy
NCT00736281 ·Status: TERMINATED ·Phase: NA
-
Single Center Food Allergy Oral Immunotherapy Study
NCT01490177 ·Status: COMPLETED ·Phase: PHASE1
-
Longitudinal Follow-up Study for Food Allergies
NCT03234764 ·Status: COMPLETED
-
The Utility of Serum Tryptase in the Diagnosis of Shrimp- Induced Anaphylaxis
NCT01619605 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Food Allergies to Proteins From Different Legumes
NCT01728168 ·Status: COMPLETED
-
Multi OIT to Test Immune Markers After Minimum Maintenance Dose
NCT03181009 ·Status: COMPLETED ·Phase: PHASE2
-
The Significance of a Timely Food Allergy Diagnosis and Optimal Surveillance of Nutritional Status in Children
NCT05287074 ·Status: ENROLLING_BY_INVITATION
-
The Natural History of Wheat Hypersensitivity in Thai Children
NCT01801748 ·Status: COMPLETED ·Phase: NA
-
Improving Diagnosis of Legume Allergy in Children
NCT06995950 ·Status: NOT_YET_RECRUITING
-
Detection of Immunotoxic Gluten Peptides in Feces
NCT01478867 ·Status: COMPLETED
-
Improving Nutrient Intake and Growth in Children With Multiple Food Allergies
NCT01571830 ·Status: COMPLETED
-
Understanding and Diagnosing Allergic Disease in Twins
NCT01613885 ·Status: COMPLETED
-
Oral Immunotherapy in Food Allergy in Finland
NCT02640014 ·Status: COMPLETED ·Phase: NA
-
Microbiota as Potential Target for Food Allergy
NCT02087930 ·Status: UNKNOWN
-
An Observational Study of Childhood Food Allergy
NCT00356174 ·Status: COMPLETED
-
Evaluation of Potential Allergenicity of New Soybean Varieties
NCT01950559 ·Status: TERMINATED
-
Major Allergen in Wheat Anaphylaxis in Thai Population
NCT03487315 ·Status: COMPLETED ·Phase: NA
-
Evaluation of The Food Allergy Mastery Program
NCT06034678 ·Status: RECRUITING ·Phase: NA
-
The Naples Pediatric Food Allergy (NAPFA) Score
NCT05707858 ·Status: COMPLETED
-
The Role of NIchel and LTPs Sensitization in Functional Gastrointestinal Disorders: the NILT Study
NCT07105865 ·Status: RECRUITING
-
Children With Aluminium Contact Allergy: Oral Exposure Study
NCT04921163 ·Status: COMPLETED ·Phase: NA
-
Improving the Safety of Oral Immunotherapy for Cow's Milk Allergy
NCT02216175 ·Status: COMPLETED ·Phase: NA